MMPP

CAS No. 1895957-18-2

MMPP( —— )

Catalog No. M34338 CAS No. 1895957-18-2

MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 606 In Stock
10MG 866 In Stock
25MG 1302 In Stock
50MG 1721 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MMPP
  • Note
    Research use only, not for human use.
  • Brief Description
    MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
  • Description
    MMPP is an anti-inflammatory agent. MMPP prevents LPS-induced mortality by inhibiting the inflammatory response via STAT3 activity inhibition.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    STAT | VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1895957-18-2
  • Formula Weight
    270.32
  • Molecular Formula
    C17H18O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/CC1=CC=C(OC)C=C1)\C2=CC(OC)=C(O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Son DJ, et, al. Novel synthetic (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol inhibits arthritis by targeting signal transducer and activator of transcription 3. Sci Rep. 2016 Nov 15:6:36852.?
molnova catalog
related products
  • HJC0152

    A potent, orally bioavailable STAT3 signaling inhibitor that exhibits promising antitumor effects in vitro and in vivo.

  • XZH-5

    XZH-5 is a small moelcule that inhibits constitutive and interleukin-6-induced STAT3 phosphorylation.

  • Ziresovir

    Ziresovir (RO-0529) is a respiratory syncytial virus fusion protein (RSV F) inhibitor that inhibits RSV activity and can be used in the study of syncytial virus sensing.